Gene interactions and stroke risk in children with sickle cell anemia

被引:125
作者
Hoppe, C
Klitz, W
Cheng, S
Apple, R
Steiner, L
Robles, L
Girard, T
Vichinsky, E
Styles, L
机构
[1] Roche Mol Syst, Dept Human Genet, Alameda, CA USA
[2] Childrens Hosp & Res Ctr, Dept Hematol Oncol, Oakland, CA USA
关键词
D O I
10.1182/blood-2003-09-3015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stroke is a devastating complication of sickle cell anemia (SCA), affecting up to 30% of children with the disease. Despite the relative frequency of stroke in SCA, few predictors of risk exist. Because stroke in SCA is likely a multifactorial disease, analysis of the combined effect of multiple genetic variants may prove more successful than evaluation of individual candidate genes. We genotyped 230 children with SCA for 104 polymorphisms among 65 candidate vascular genes to identify risk associations with stroke. Patients were phenotyped based on magnetic resonance imaging/angiography (MRI/MRA) findings into large-vessel (LV) versus small-vessel (SV) disease stroke subgroups. Specific polymorphisms in the IL4R 503, TNF (-308), and ADRB2 27 genes were independently associated with stroke susceptibility in the LV stroke subgroup, while variants in the VCAM1 (-1594) and LDLR Ncol genes were associated with SV stroke risk. The combination of TNF (-308)GG homozygosity and the IL4R 503P variant carrier status was associated with a particularly strong predisposition to LV stroke (odds ratio [OR] = 5.5; 95% confidence interval [CI] 2.3-13.1). We show that several candidate genes may play a role in predisposition to specific stroke subtypes in children with SCA. If confirmed, these results provide a basis for population screening and targeted intervention to prevent stroke in SCA. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2391 / 2396
页数:6
相关论文
共 42 条
[1]   ALPHA-THALASSEMIA AND STROKE RISK IN SICKLE-CELL-ANEMIA [J].
ADAMS, RJ ;
KUTLAR, A ;
MCKIE, V ;
CARL, E ;
NICHOLS, FT ;
LIU, JC ;
MCKIE, K ;
CLARY, A .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 45 (04) :279-282
[2]  
Andrade FL, 1998, AM J HEMATOL, V59, P46, DOI 10.1002/(SICI)1096-8652(199809)59:1<46::AID-AJH9>3.0.CO
[3]  
2-#
[4]   The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults [J].
Balasa, VV ;
Gruppo, RA ;
Glueck, CJ ;
Stroop, D ;
Becker, A ;
Pillow, A ;
Wang, P .
THROMBOSIS AND HAEMOSTASIS, 1999, 81 (05) :739-744
[5]   Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion [J].
Belcher, JD ;
Marker, PH ;
Weber, JP ;
Hebbel, RP ;
Vercellotti, GM .
BLOOD, 2000, 96 (07) :2451-2459
[6]  
Carroll JE, 1998, AM J HEMATOL, V58, P250, DOI 10.1002/(SICI)1096-8652(199807)58:3<250::AID-AJH22>3.0.CO
[7]  
2-C
[8]   A multilocus genotyping assay for candidate markers of cardiovascular disease risk [J].
Cheng, S ;
Grow, MA ;
Pallaud, C ;
Klitz, W ;
Erlich, HA ;
Visvikis, S ;
Chen, JJ ;
Pullinger, CR ;
Malloy, MJ ;
Siest, G ;
Kane, JP .
GENOME RESEARCH, 1999, 9 (10) :936-949
[9]   The prothrombin gene G20210A variant: Prevalence in a UK anticoagulant clinic population [J].
Cumming, AM ;
Keeney, S ;
Salden, A ;
Bhavnani, M ;
Shwe, KH ;
Hay, CRM .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :353-355
[10]   A major role for VCAM-1, but not ICAM-1, in early atherosclerosis [J].
Cybulsky, MI ;
Iiyama, K ;
Li, HM ;
Zhu, SN ;
Chen, M ;
Iiyama, M ;
Davis, V ;
Gutierrez-Ramos, JC ;
Connelly, PW ;
Milstone, DS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (10) :1255-1262